You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022183014
Dec 20223604
Jan 20233002
Feb 20234405
Mar 20232202
Apr 20232801
May 20232201
Jun 20233201
Jul 20232806
Aug 20233004
Sep 20232001
Oct 20234802
Nov 20233602
Dec 20234602
Jan 20243602
Feb 20243802
Mar 20241203
Apr 20243400
May 20242805
Jun 20243802
Jul 20244603
Aug 20241403
Sep 20242203
Total873070